2017
DOI: 10.1002/14651858.cd011252.pub2
|View full text |Cite
|
Sign up to set email alerts
|

Medical and dietary interventions for preventing recurrent urinary stones in children

Abstract: Oral potassium citrate supplementation may reduce recurrent calcium urinary stone formation in children following SWL; however, our confidence in this finding is limited. A substantial number of children stopped the medication due to adverse events. There is no trial evidence on retreatment rates. There is a critical need for additional well-designed trials in children with nephrolithiasis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
9
0
4

Year Published

2017
2017
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(14 citation statements)
references
References 41 publications
1
9
0
4
Order By: Relevance
“…Potassium citrate binds with sodium in urine and decreases sodium level in urine, increases pH of urine, and ultimately reduces stone formation [ 21 ]. These results were in line with available studies [ 11 , 12 , 20 ]. Potassium citrate is effective in treatment of pediatric urolithiasis.…”
Section: Discussionsupporting
confidence: 93%
See 1 more Smart Citation
“…Potassium citrate binds with sodium in urine and decreases sodium level in urine, increases pH of urine, and ultimately reduces stone formation [ 21 ]. These results were in line with available studies [ 11 , 12 , 20 ]. Potassium citrate is effective in treatment of pediatric urolithiasis.…”
Section: Discussionsupporting
confidence: 93%
“…A high fluid intake prevents caliceal stones formation by decreasing supersaturation and citrate prevents caliceal stones formation by ionization of urinary calcium [ 10 ]. Lemons, oranges, and grapes are recommended in pediatric urolithiasis [ 11 , 12 ]. Lemonade has 110 mg/kg calcium and 490 g/kg citric acid.…”
Section: Introductionmentioning
confidence: 99%
“…The rationale for using citrate salts in kidney stone disease was explained in previous paragraphs and was based on four main issues: (1) citrate salts are rapidly absorbed through the intestine and equally rapidly filtered in the urine; (2) citrate forms calcium citrate complexes, which in turn increase solubility and decrease the amount of free calcium in urine; (3) citrate acts as an inhibitor of CaOx and CaP crystal growth and aggregation, and (4) in the intestine, the complexation between calcium and citrate reduces enteric absorption of calcium, and therefore renal excretion. A recent systematic review has demonstrated that citrate-based therapy reduced recurrent calcium urinary stone formation compared to controls (placebo, usual care) [135]; however, evidence was limited in children [136].…”
Section: Medical Management Of Patients With Metabolic Bone Diseasmentioning
confidence: 99%
“…Kan ve idrarın analizi metabolik değerlendirmenin önemli bir parçasıdır, ancak risk değerlendirmesinin ne kadar kapsamlı olması gerektiği taş tipi ve hastalığın ciddiyeti tarafından belirlenir. Postoperatif dönemde uygun hastalarda medikal tedavi ile koruma yapılması taş nüksünü azaltmaktadır (21)(22)(23). İyi yönetilen bir koruyucu tıbbi tedavi sayesinde, taş oluşum aktivitesi vakaların %80' inden fazlasında durdurulabilir (22).…”
Section: Discussionunclassified